BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27311985)

  • 1. MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes.
    Jin Y; Yu D; Tolleson WH; Knox B; Wang Y; Chen S; Ren Z; Deng H; Guo Y; Ning B
    Biochem Pharmacol; 2016 Aug; 113():88-96. PubMed ID: 27311985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1.
    Wang Y; Yu D; Tolleson WH; Yu LR; Green B; Zeng L; Chen Y; Chen S; Ren Z; Guo L; Tong W; Guan H; Ning B
    Biochem Pharmacol; 2017 Aug; 138():174-184. PubMed ID: 28438567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation.
    Zeng L; Chen Y; Wang Y; Yu LR; Knox B; Chen J; Shi T; Chen S; Ren Z; Guo L; Wu Y; Liu D; Huang K; Tong W; Yu D; Ning B
    Biochem Pharmacol; 2017 Sep; 140():139-149. PubMed ID: 28552654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease.
    Luo J; Xie M; Hou Y; Ma W; Jin Y; Chen J; Li C; Zhao K; Chen N; Xu L; Ji Y; Zhang Q; Zheng Y; Yu D
    Biochem Pharmacol; 2021 Jun; 188():114582. PubMed ID: 33895159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.
    Chen Y; Zeng L; Wang Y; Tolleson WH; Knox B; Chen S; Ren Z; Guo L; Mei N; Qian F; Huang K; Liu D; Tong W; Yu D; Ning B
    Biochem Pharmacol; 2017 Dec; 145():178-191. PubMed ID: 28822783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells.
    Yu D; Green B; Tolleson WH; Jin Y; Mei N; Guo Y; Deng H; Pogribny I; Ning B
    Biochem Pharmacol; 2015 Nov; 98(1):215-23. PubMed ID: 26296572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.
    Yu D; Green B; Marrone A; Guo Y; Kadlubar S; Lin D; Fuscoe J; Pogribny I; Ning B
    Sci Rep; 2015 Feb; 5():8534. PubMed ID: 25704921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of miRNAs that regulate human CYP2B6 expression.
    Nakano M; Iwakami C; Fukami T; Nakajima M
    Drug Metab Pharmacokinet; 2021 Jun; 38():100388. PubMed ID: 33872945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells.
    Yu D; Tolleson WH; Knox B; Jin Y; Guo L; Guo Y; Kadlubar SA; Ning B
    Biochem Pharmacol; 2015 Dec; 98(4):671-80. PubMed ID: 26428001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs hsa-miR-495-3p and hsa-miR-486-5p suppress basal and rifampicin-induced expression of human sulfotransferase 2A1 (SULT2A1) by facilitating mRNA degradation.
    Li D; Knox B; Chen S; Wu L; Tolleson WH; Liu Z; Yu D; Guo L; Tong W; Ning B
    Biochem Pharmacol; 2019 Nov; 169():113617. PubMed ID: 31445882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans.
    Yu D; Wu L; Gill P; Tolleson WH; Chen S; Sun J; Knox B; Jin Y; Xiao W; Hong H; Wang Y; Ren Z; Guo L; Mei N; Guo Y; Yang X; Shi L; Chen Y; Zeng L; Dreval K; Tryndyak V; Pogribny I; Fang H; Shi T; McCullough S; Bhattacharyya S; Schnackenberg L; Mattes W; Beger RD; James L; Tong W; Ning B
    Arch Toxicol; 2018 Feb; 92(2):845-858. PubMed ID: 29067470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A GDF15 3' UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p.
    Teng MS; Hsu LA; Juan SH; Lin WC; Lee MC; Su CW; Wu S; Ko YL
    PLoS One; 2017; 12(8):e0183187. PubMed ID: 28806401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.
    Haenisch S; Zhao Y; Chhibber A; Kaiboriboon K; Do LV; Vogelgesang S; Barbaro NM; Alldredge BK; Lowenstein DH; Cascorbi I; Kroetz DL
    Neurobiol Dis; 2015 May; 77():127-40. PubMed ID: 25766675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diosbulbin B induced G
    Yang R; Wei M; Yang F; Sheng Y; Ji L
    Toxicol Appl Pharmacol; 2018 Oct; 357():1-9. PubMed ID: 30145177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor.
    Faucette SR; Sueyoshi T; Smith CM; Negishi M; Lecluyse EL; Wang H
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1200-9. PubMed ID: 16513849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
    Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
    Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophoretic Mobility Shift Assay (EMSA) and Supershift Assay of Cytochrome P450 2B6 in Response to Estrogen.
    Koh KH; Jeong H
    Methods Mol Biol; 2016; 1366():41-51. PubMed ID: 26585126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the Human Fc-Neonatal Receptor alpha-Chain Gene FCGRT by MicroRNA-3181.
    Ferguson DC; Blanco JG
    Pharm Res; 2018 Jan; 35(1):15. PubMed ID: 29302759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Regulation of Human Hepatic Constitutive Androstane Receptor by Cholesterol Synthesis Inhibition: Role of Sterol Regulatory Element Binding Proteins.
    Cuko L; Duniec-Dmuchowski Z; Rondini EA; Pant A; Fallon JK; Wilson EM; Peraino NJ; Westrick JA; Smith PC; Kocarek TA
    Drug Metab Dispos; 2021 Aug; 49(8):706-717. PubMed ID: 34011532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.